Dr. Scott P. Striplin, M.D.
OB-GYN (Obstetrics & Gynecology) (Obstetrics & Gynecology Physician)
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 13
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: University of Alabama School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Obstetrics & Gynecology Physician primary
LA license 1234R
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: OB-GYN (Obstetrics & Gynecology) per capita by county →
Where they work
Hospitals
- St Tammany PArish Hospital Covington, LA
Medical groups
- St Tammany PArish Hospital Service District No 1 (166 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 13
- Services billed
- 22
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 19 | 13 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 16 | 16 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Estradiol Other prescribers in Covington, LA | 127 |
| Premarin (estrogens, conjugated) Other prescribers in Covington, LA | 25 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Covington, LA | 24 |
| Fluconazole Other prescribers in Covington, LA | 18 |
| Medroxyprogesterone Acetate Other prescribers in Covington, LA | 15 |
| Clotrimazole-Betamethasone (clotrimazole/betamethasone dip) Other prescribers in Covington, LA | 13 |
| Progesterone (progesterone, micronized) Other prescribers in Covington, LA | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 26 industry-funded studies in 2025, from 11 companies. The companies reported $1,254,121 in research payments for these studies, mostly to the institutions running them.
- A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
ModernaTX, Inc. · Completed · NCT06602024 - A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Eli Lilly and Company · Completed · NCT06373146 - Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults
Sanofi Pasteur Inc. · Completed · NCT07002060 - A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age
ModernaTX, Inc. · Completed · NCT06634797 - NB (Contrave) Cardiovascular Outcomes Trial
Currax Pharmaceuticals LLC - A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus
ModernaTX, Inc. · Completed · NCT06097299 - A Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared …
AstraZeneca Pharmaceuticals LP - A phase i/ii observer-blind, randomized, multi-center trial to evaluat
GlaxoSmithKline, LLC. - Post marketing commitment study to assess clinical efficacy & safety of current JN.1-based formulation with focus on lower-risk adults (50-64 years) to inform benefit-risk profile (PMC2)
ModernaTX, Inc. - A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above
Sanofi Pasteur Inc. · Completed · NCT06361875
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.